Palliative treatment of hepatocellular carcinoma. Is it justified?

被引：0

作者：

Michalowicz, B ^{[1
]}

Alsharabi, A ^{[1
]}

Pawlak, J ^{[1
]}

Krawczyk, M ^{[1
]}

Paczkowski, PM ^{[1
]}

Malkowski, P ^{[1
]}

Zieniewicz, K ^{[1
]}

Nyckowski, P ^{[1
]}

Karwowski, A ^{[1
]}

Rowinski, O ^{[1
]}

Jaworski, M ^{[1
]}

Leowska, E ^{[1
]}

机构：

[1] Univ Warsaw, Dept Gen & Liver Surg, Warsaw, Poland

来源：

8TH WORLD CONGRESS OF THE INTERNATIONAL GASTRO-SURGICAL CLUB | 1998年

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

In the period 1992-1995 313 patients were treated for malignant liver tumors. The diagnosis of hepatocellular carcinoma was established in 118 cases. In 84 cases the tumor was inoperable. We present our experience with intraoperative alcoholization (19 cases) and perarterial chemoembolization (43 cases). None of these methods is effective in all cases. Etanol injection resulted in temporary reduction of the neoplasmatic mass in 73%. Repeated chemoembolization resulted in significant improvement in 20 cases, in 16 cases it's effect was doubtful and in 7 cases it was evidently uneffective. 18 patients (42%) survived more than one year, in 15 of them no progress of malignancy was noticed.

引用

页码：413 / 418

页数：6

共 50 条

[21] Liver Transplantation Versus Liver Resection for the Treatment of Hepatocellular Carcinoma.
Park, Min-Su
Lee, Kwang-Woong
Suh, Suk-Won
You, Tae
Kim, Hyeyoung
Choi, YoungRok
Hong, Geun
Yi, Nam-Joon
Suh, Kyung-Suk
Kwon, Choon-Hyuck David
Joe, Jae-Won
Lee, Suk-Koo
LIVER TRANSPLANTATION, 2013, 19 : S118 - S119
[22] PALLIATIVE TREATMENT OF PRIMARY HEPATOCELLULAR-CARCINOMA WITH CHEMOEMBOLIZATION
HASAN, I
WICKENHOFER, R
GORICH, J
HARTLAPP, JH
REISER, M
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 117 (15) : 576 - 580
[23] Hepatic resection of hepatocellular carcinoma.
Que, FG
Gigot, JF
Harmsen, WS
Nagornev, DM
HEPATOLOGY, 1997, 26 (04) : 466 - 466
[24] Cytotoxic chemotherapy for hepatocellular carcinoma.
Beuzeboc, P
SEMAINE DES HOPITAUX, 1996, 72 (21-22): : 654 - 659
[25] Liver Transplantation Versus Liver Resection in the Treatment of Hepatocellular Carcinoma.
Guo, Zhiyong
Ju, Weiqiang
Zheng, Zheng
He, Xiaoshun
LIVER TRANSPLANTATION, 2013, 19 : S277 - S277
[26] Benefits of percutaneous ethanol injection in the treatment of advanced hepatocellular carcinoma.
Misauno, Micheal Ayedima
Isichei, Mercy Wakili
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[27] A real-world study of camrelizumab in the treatment of hepatocellular carcinoma.
Zeng, Yong-Yi
Guo, Wu-hua
Zhang, Zhibo
Shi, Xi
Su, Yongjie
Cai, Qinghe
Peng, Jianyang
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[28] Comparative analysis of eastern and western treatment practices for hepatocellular carcinoma.
Kin, Cindy
Lo, Irene J.
Wang, Chih-Chi
Lin, Chi-Che
Kinkhabwala, Milan
Lu, Sheng-Nan
Chen, Chao-Long
Emond, Jean C.
Renz, John F.
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 467 - 467
[29] Hepatocellular carcinoma. Pathogenesis and multicentricity
Blum, HE
Hopt, UT
CHIRURG, 2003, 74 (08): : 709 - 716
[30] Genetic alterations in hepatocellular carcinoma.
Boige, V
LaurentPuig, P
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1997, 21 (01): : 34 - 44

← 1 2 3 4 5 →